JPRN-UMIN000014492已完成2 期
A trial of prospective adjuvant chemotherapy in patients with resectable colorectal cancer with heaptic metastasis - A trial of prospective adjuvant chemotherapy in patients with resectable colorectal cancer with heaptic metastasis
Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine0 个研究点目标入组 40 人开始时间: 2014年7月7日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. multiple primary cancer 2. Serious postoperative complications 3. Case with the following complications -Poor control diabetes mellitus -Poor control hypertention -Myocardial infarction or unstable angina within six months. -Interstitial pneumonia, pulmonary fibrosis, severe pulmonary emphysema 4. Case with the following -A pregnant woman or the women who may be pregnant or hope to be pregnant -lactating women 5. The patients complicated with psychosis or neurologic manifestation, and judged to have difficulty in participation in clinical trials. 6. The case judged to be unsuitable for registration
研究者
相似试验
已完成
3 期
A randomized trial of adjuvant chemotherapy in resected stage I lung adenocarcinoma with high SUV index. JNETS 1201ung cancerJPRN-UMIN000007790Japanese Northern East Area Thoracic Surgery Study Group (JNETS-SG)460
进行中（未招募）
1 期
Study of chemotherapy vs immunotherapy for patients with lung cancer bounded inthe thorax and completely resectedResectable Non-small cell lung cancerMedDRA version: 21.1Level: LLTClassification code: 10029514Term: Non-small cell lung cancer NOS Class: 10029104MedDRA version: 20.0Level: SOCClassification code: 10029104Term: Neoplasms benign malignant and unspecified (incl cysts and polyps) Class: 2CTIS2024-513730-38-00Fundacion GECP210
招募中
1 期
Phase I trial of adjuvant chemotherapy with modified S-1 and propagermanium for pancreatic cancerpancreatic cancerJPRN-UMIN000017715Osaka University Hospital10
已完成
不适用
Feasibility study of adjuvant chemotherapy consisting of FEC(fluoraouracil, epirubicin and cyclophosphamide) followed by DH(docetaxel+herceptin) for patients with HER2 positive breast cancerBreast cancerJPRN-UMIN000001583Kyushu Breast Cancer Study Group45
已完成
不适用
Phase I Study of adjuvant chemotherapy for the patients resected pathological stage IA(T1>2cm) Non Small Cell Lung Cancer (SLCG0701)JPRN-UMIN000006967Setouchi Lung Cancer Group80